The ASHP accredited PGY2 Oncology Pharmacy Residency at KCC is a twelve-month program that provides advanced clinical training and experience in the management of patients with malignant disease. The oncology resident will have the opportunity to collaborate with hematologists/oncologists, fellows, clinical pharmacy specialists, and Wayne State University (WSU) faculty to build on and gain knowledge in a wide variety of areas. The oncology specialized residency program will be tailored to the needs of the resident based on previous clinical experience.
The resident is required to complete the core rotations set forth for the residency program, as well as participate in longitudinal ambulatory experiences. Optional experience is offered in infectious disease, critical care, and nutrition support with the focus of an oncology setting. The resident is expected to participate in patient care rounds, develop expertise in providing pharmaceutical care to hematology/oncology patients, provide leadership to pharmacy practice residents and doctor of pharmacy students as well as participate in the development of clinical pathways, medication safety, and drug-use protocols for the hospital in conjunction with the KCC P&T Committee. The resident will be responsible for the completion of at least one research project of publishable quality and will have the opportunity for didactic teaching at WSU.
The applicant must be an enthusiastic and highly motivated graduate of a college of pharmacy accredited in the United States and must be licensed or eligible for licensure in the State of Michigan. Interested candidates should possess a Doctor of Pharmacy degree and have completed a PGY1 pharmacy practice residency.
Additional Salary Information: The resident will receive a competitive stipend, health-care coverage, and paid personal and professional leave. The resident will have the opportunity to attend professional meetings during the year.
About Karmanos Cancer Hospital
Karmanos Cancer Institute, headquartered in Detroit, understands that beating cancer means bringing together the best. Cancer is a complex disease that demands complex care. With 16 locations throughout Michigan and proudly a part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in the state. Cancer patients have increased access to advanced cancer care in communities throughout the state. This provides an extra level of comfort and peace of mind to patients and their families, knowing they can receive the best care locally.
Caring for approximately 12,000 new patients annually and conducting more than 800 cancer-specific scientific investigation programs and clinical trials, Karmanos is among the nation’s best cancer centers. Karmanos offers one of the largest clinical trials program in the nation, giving patients access to more than 250 promising new treatments often not found at other hospitals or health organizations.
Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, Karmanos strives to lead in transformative cancer care, research and education thro...ugh courage, commitment and compassion. Our long-term partnership with the Wayne State University School of Medicine enhances the collaboration of critical research and academics related to cancer care.
Our Vision: A world free of cancer
Our Mission: To lead in transformative cancer care, research and education through courage, commitment and compassion